AGIO:NASDAQ
Agios Pharmaceuticals Inc
$33.08
arrow_upward
+0.56%(+0.18) 1D
Sep 25, 12:15:04 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
$32.93
High
$33.27
Low
$32.65
Mkt. cap
1.98B
Avg. vol.
933.02K
Volume
220.54K
52-wk high
$45.99
52-wk low
$22.24
EPS
-$7.01
Beta
0.60
Shares outstanding
59.70M
No. of employees
540
Open
$32.93
High
$33.27
Low
$32.65
Mkt. cap
1.98B
Avg. vol.
933.02K
Volume
220.54K
52-wk high
$45.99
52-wk low
$22.24
EPS
-$7.01
Beta
0.60
Shares outstanding
59.70M
No. of employees
540
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc